How We Got Started

Why is NK-CLK effective?

After years of extensive research at one of the nation's leading biomedical research universities, we have specially selected bacterial strains that would survive harsh environmental conditions like temperature and acidity to ensure the maximum benefit to your gut. These strains were also specifically combined to help grow and activate the NK cells in your body. Additionally, the 7 strains add to the diversity of your gut flora and help to decrease inflammation within your body restoring your immune system.

On April 4th, 2023, NK-CLK was granted U.S. Patent No: 11,617,771 for "ORAL COMPOSITION COMPRISING LACTIC ACID BACTERIA FOR REGULATING IMMUNE RESPONSES AND METHODS RELATED THERETO".

What does NK-CLK stand for?

It stands for “Natural Killer - Cytotoxic Lymphocyte King.” The research team coined this name in honor of Chen Ling Kou, who passed away after a 4-year battle with pancreatic cancer in April 2019. She was a beloved mother, wife, and friend who radiated warmth and kindness. The team sorely misses her and hopes to continue to honor her memory.

What are Natural Killer (NK) Cells and what do they do?

NK cells play an important part in your immune system. They are a type of white blood cell that kill virally infected cells. Recent studies suggest that NK cells may also help control and limit the spread of aggressive types of cancer.

What does this mean?

Recent studies and clinical observations suggest that, along with your immune system, NK-CLK may help prevent or slow cancer progression, inhibit tumor growth and metastasis, and increase the effectiveness of chemotherapy. Research indicates that when activated, NK cells, can help the aggressive tumors change into less aggressive tumors, which are more susceptible to chemotherapy and radiation treatments. Further studies have found that probiotics may also help restore NK cell functions to kill the seeds of cancer called “cancer stem cells,” which renew and increase the number of tumor cells. Researchers believe that NK cells kill those cancer stem cells and by doing so, remove the diseased parts of tissues without harming the healthy part of your cells. NK-CLK was developed to reduce levels of inflammation in your body that could fuel cancer and cause other immune system imbalances like allergies, autoimmune diseases, and other digestive issues.

Dr. Anahid Jewett

Dr. Jewett is Professor and Director of tumor immunology laboratory at the UCLA School of Dentistry and Medicine. She has published seminal work in tumor immunology and cancer immunotherapy, in particular NK immunotherapy.She holds many key patents, and has given more than 200 invited lectures nationally and internationally and has published greater than 100 research articles and has served on several NIH study section panels. She has trained more than 150 graduate students and health professionals in her laboratory. She is well-known nationally and internationally for her contribution to the field of NK biology, tumor immunology and cancer immunotherapy. 

Read About Her Research

NK-CLK is dedicated to Chen Ling Kou

Chen Ling Kou, a devoted wife, mother, and dedicated community member, passed away after battling pancreatic cancer on April 6, 2019 at the age of 55. Chen Ling was born on November 5, 1963 in Cheongju-si, South Korea. She is fondly remembered by her five siblings as a sweet, bubbly, and beautiful spirit. She was a brilliant student and her diligent studies would regularly place her in the top ranks of her classes in Seoul. She immigrated with her family in 1982 to Los Angeles, where she met her husband, Mr. Ming Shin Kou. They enjoyed thirty-two years of a truly blessed and happy union.